Funding
Who raised, when, and from whom? Explore announced rounds, including emerging Indian companies, and company-reported SEC notices. Each amount keeps its original source and date.
330 filings · Form D notices of private raises, 2024-01-02 to 2026-03-31
Shuttle Pharmaceuticals Holdings, Inc.Pharmaceuticals
Gaithersburg, Maryland · Convertible, Convertible Note and Warrant to Purchase Common Stock · 5 investors · Joshua Schafer, Chris Senanayake
Pharmaceutics International, Inc.Pharmaceuticals
Hunt Valley, Maryland · Equity · 3 investors · David Solomon, Mark Kavulich
Earth Science Tech, Inc.Pharmaceuticals
Miami, Florida · Equity · 62 investors · Giorgio Saumat
Spectrum Antimicrobials, Inc.Pharmaceuticals
Petaluma, California · Equity · 108 investors · Jerry Stonemetz, William Watson III
OnKure Therapeutics, Inc.Pharmaceuticals
Boulder, Colorado · Equity · 20 investors · Isaac Manke, Jason Leverone
ASCENDIA PHARMACEUTICALS, INC.Pharmaceuticals
New BRUNSWICK, New Jersey · founded 2021 · Equity · 2 investors · James Gale, Shoufeng Li
Cytogel Pharma, LLCPharmaceuticals
Darien, Connecticut · Equity, Options · 18 investors · C. Maglaris, Theodore Maione
Clene Inc.Pharmaceuticals
Salt Lake City, Utah · founded 2020 · Equity, Options, Convertible · 13 investors · Alison Mosca, Mark Mortenson
CERO THERAPEUTICS HOLDINGS, INC.Pharmaceuticals
South San Francisco, California · founded 2021 · Equity, Options, Convertible · 13 investors · Kristen Pierce, Michael Byrnes
Indaptus Therapeutics, Inc.Pharmaceuticals
New York, New York · founded 2021 · Options, Convertible · 12 investors · Anthony Maddaluna, William Hayes
Synedgen, Inc.Pharmaceuticals
Claremont, California · Debt · 4 investors · Shenda Baker, William Wiesmann
Ophidion Inc.Pharmaceuticals
Bethlehem, Pennsylvania · Debt, Options · 8 investors · Michael Lark, Yacoub Habib
VACCINEX, INC.Pharmaceuticals
Rochester, New York · Options, Convertible · 8 investors · Jacob Frieberg, Gerald Van Strydonck
Revitalize Energy, Inc.Pharmaceuticals
Pittsburgh, Pennsylvania · founded 2021 · Options · 2 investors · Kyle Guinness, Tammy Szijarto
Rivus Pharmaceuticals, Inc.Pharmaceuticals
Charlottesville, Virginia · Equity · 7 investors · Ian Smith, Allen Cunningham
Rivus Pharmaceuticals, Inc.Pharmaceuticals
Charlottesville, Virginia · Equity · 7 investors · Ian Smith, Allen Cunningham
STAQ Pharma, Inc.Pharmaceuticals
Denver, Colorado · Equity · 8 investors · Scott Hawig, Mark Spiecker
Spectrum Antimicrobials, Inc.Pharmaceuticals
Petaluma, California · Equity, Debt · 28 investors · Kate Lewis, Jerry Stonemetz
OWP PHARMACEUTICALS, INC.Pharmaceuticals
Naperville, Illinois · Equity · 11 investors · Steve Bourne, Carol Gavin
Solaxa Inc.Pharmaceuticals
Bethesda, Maryland · founded 2021 · Equity · 4 investors · Luis Gutierrez, Lauren Sabella
Rhoshan Pharmaceuticals, Inc.Pharmaceuticals
State College, Pennsylvania · Equity · 3 investors · Hitha Palepu, Nagesh Palepu
Centaur Bio Inc.Pharmaceuticals
Charlotte, North Carolina · founded 2021 · Debt, Options · 26 investors · Michael Roberts
Pharmazz, Inc.Pharmaceuticals
Willowbrook, Illinois · Options, Convertible · 1 investors · David Costello, James McConnell
TENAX THERAPEUTICS, INC.Pharmaceuticals
Chapel Hill, North Carolina · Equity, Options, Convertible · 24 investors · Michael Davidson, Stuart Rich
Pelage Pharmaceuticals, Inc.Pharmaceuticals
Los Angeles, California · Equity · 6 investors · Cathy Friedman, William Lowry
DepYmed Inc.Pharmaceuticals
Farmingdale, New York · Equity · 2 investors · Shankar Hariharan, Andreas Grill
Medsyn Biopharma LLCPharmaceuticals
Northville, Michigan · Equity · 5 investors · John Sorensen
LIPELLA PHARMACEUTICALS INC.Pharmaceuticals
Pittsburgh, Pennsylvania · Equity, Options, Convertible · 1 investors · Douglas Johnston, Michael Chancellor
Enlaza Therapeutics, Inc.Pharmaceuticals
La Jolla, California · founded 2020 · Equity · 16 investors · Marcos Milla, Jay Lichter
Chromocell Therapeutics CorpPharmaceuticals
Freehold, New Jersey · founded 2021 · Debt, Convertible, The convertible note is convertible into the company's common · 1 investors · Francis Knuettel, Todd Davis